Cell Signaling Technology

VEGF Receptor 3 (C82A2) Rabbit Monoclonal Antibody

#3408 · western blot · $158,348

66
Evidence Score · Well-Established
Used by 297 independent labs across 313 papers. How we score this →
100
Citing papers
10.4k
Combined citations
Supplier page Find this product

Research areas

Cytokine Signaling Pathways and Interactions13Immune Cell Function and Interaction8Epigenetics and DNA Methylation7Cancer Cells and Metastasis7Acute Myeloid Leukemia Research6Cancer-related molecular mechanisms research6Adipose Tissue and Metabolism5Cancer Immunotherapy and Biomarkers5

Papers citing this product

1
AC220 is a uniquely potent and selective inhibitor of FLT3 for the treatment of acute myeloid leukemia (AML)
Blood·2009·641 cit.·DOI
2
Eribulin mesilate suppresses experimental metastasis of breast cancer cells by reversing phenotype from epithelial–mesenchymal transition (EMT) to mesenchymal–epithelial transition (MET) states
British Journal of Cancer·2014·355 cit.·DOI
3
Constitutively Active Inflammasome in Human Melanoma Cells Mediating Autoinflammation via Caspase-1 Processing and Secretion of Interleukin-1β
Journal of Biological Chemistry·2009·292 cit.·DOI
4
Recent Advances in Targeting ROS1 in Lung Cancer
Journal of Thoracic Oncology·2017·259 cit.·DOI
5
The m6A demethylase ALKBH5 controls trophoblast invasion at the maternal-fetal interface by regulating the stability of <i>CYR61</i> mRNA
Theranostics·2019·253 cit.·DOI
6
TGFβ1 secreted by cancer-associated fibroblasts induces epithelial-mesenchymal transition of bladder cancer cells through lncRNA-ZEB2NAT
Scientific Reports·2015·251 cit.·DOI
7
Monocytes Induce STAT3 Activation in Human Mesenchymal Stem Cells to Promote Osteoblast Formation
PLoS ONE·2012·240 cit.·DOI
8
PD-1 and PD-L1 Expression in NSCLC Indicate a Favorable Prognosis in Defined Subgroups
PLoS ONE·2015·228 cit.·DOI
9
Megakaryocyte-specific RhoA deficiency causes macrothrombocytopenia and defective platelet activation in hemostasis and thrombosis
Blood·2011·174 cit.·DOI
10
Identification of Two Distinct Carcinoma-Associated Fibroblast Subtypes with Differential Tumor-Promoting Abilities in Oral Squamous Cell Carcinoma
Cancer Research·2013·172 cit.·DOI

Similar products

ProductVendorEvidencePricePapers
VEGF Receptor 3 AntibodyRabbitCell Signaling Technology66$394100
VEGF Receptor 3 (C28G5) Rabbit Monoclonal AntibodyRabbitCell Signaling Technology66$158,348100
VEGF Receptor 3 (D1J9Z) Rabbit Monoclonal AntibodyRabbitCell Signaling Technology66$161,35115

Rate this reagent

Used this in your lab? Leave a quick rating. Reviews are anonymous and verified by academic email before they appear.

Your email is never shown publicly.